Iron metabolism in transplantation

Area of Science:

• Transplantation Medicine
• Immunology
• Metabolic Disorders

Background:

• Recipient iron status is a critical factor influencing clinical outcomes in transplantation.
• Iron plays multifaceted roles in ischemia-reperfusion injury, immune modulation, and organ function post-transplant.

Purpose of the Study:

• To review the role of iron metabolism in solid organ transplantation.
• To discuss the impact of iron deficiency and overload on immune activation and patient prognosis.
• To highlight the need for optimized iron management in transplant candidates and recipients.

Main Methods:

• Literature review focusing on iron metabolism in solid organ transplantation.
• Analysis of studies investigating iron's role in ischemia-reperfusion injury.
• Examination of molecular mechanisms linking iron status to immune activation and clinical outcomes.

Main Results:

• Iron chelators show promise in reducing ischemia-reperfusion injury in preclinical models, but clinical application is limited.
• Both iron deficiency and iron overload are associated with reduced immune activation.
• Iron overload and hyperferritinemia correlate with poor prognosis in end-stage organ failure and persist post-transplantation.
• Iron deficiency and anemia are linked to poor outcomes in heart failure patients.

Conclusions:

• Iron overload and iron deficiency represent significant risk factors before and after solid organ transplantation.
• Active management of iron status is crucial for patients on transplant waiting lists and post-transplant.
• Careful administration of intravenous iron is necessary to prevent persistent iron overload after transplantation.